RetinaCare Complete:
Restoring Vision. Improving Lives.
Helping ophthalmology practices simplify specialty drug access.
RetinaCare Complete, a new program from Acelpa Health that’s available through California Specialty Pharmacy and Hawaii Specialty Pharmacy, helps you keep pace with today’s challenges and take advantage of expanding opportunities.
RetinaCare Complete is an ophthalmology specialty pharmacy program designed to help you provide high-volume ophthalmic services. No more delays. No more frustrations. This end-to-end solution helps streamline drug access processes, simplify provider workflows and support cost efficiency. With RetinaCare Complete, you improve the supply and delivery of ophthalmic specialty medications while providing greater certainty for patients, providers and payors. Our specialty pharmacy ophthalmology service benefits include a dedicated care team available to assist when needed, and:
Provider Benefits
- 24–48-hour turnaround on most prescriptions
- Clear, consistent medication ordering and delivery process
- Streamlined prior authorization support and benefits investigation
- Reliable access to specialty medications and hard-to‑source ophthalmic drugs
- Predictable supply for high-volume injection schedules
- Continued focus on delivering high-quality patient care
- Coordinated support across pharmacy, providers and health plans
Payor Benefits
- Supports adherence and patient care outcomes
- Enhances visibility and management of ophthalmology specialty drug costs
- Helps reduce waste through coordinated refill processes
- Improves data visibility and financial planning insights
- Supports clinically appropriate site-of-care alignment in accordance with payor policies
- Reliable compounding and supply processes
- Aligned provider–pharmacy–plan workflow
The Medications You Need, When You Need Them
The RetinaCare Complete program provides access to a broad portfolio of specialty medications used in the treatment of complex retinal conditions. Through coordinated sourcing and delivery, we ensure therapies are available to support consistent treatment schedules and continuity of care. Those medications include the following:
- AVASTIN® (bevacizumab)
- BEOVU® (brolucizumab-dbll)
- BYOOVIZ® (ranibizumab-nuna)
- HEALON® (sodium hyaluronate)
- HEALON5® (sodium hyaluronate)
- IZERVAY® (avacincaptad pegol)
- LUCENTIS® (ranibizumab)
- OZURDEX® (dexamethasone)
- PAVBLU® (aflibercept-ayyh)
- PROVISC® (sodium hyaluronate)
- SUSVIMO® (ranibizumab)
- TEPEZZA® (teprotumumab-trbw)
- TRIESENCE® (triamcinolone acetonide)
- VABYSMO® (faricimab-svoa)